Abstract
As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Current Bioinformatics
Title: Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †
Volume: 7 Issue: 1
Author(s): Qiuli Liu, Xianping Guo and Tianshou Zhou
Affiliation:
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Abstract: As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Export Options
About this article
Cite this article as:
Liu Qiuli, Guo Xianping and Zhou Tianshou, Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †, Current Bioinformatics 2012; 7 (1) . https://dx.doi.org/10.2174/157489312799304486
DOI https://dx.doi.org/10.2174/157489312799304486 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Infrared Spectroscopy and Imaging in Cancer Diagnosis
Current Medicinal Chemistry Bioactivities of Rubidium Chloride-Poly (4-Vinylpyridine) Composite Fabricated Via Sol Gel Technique
Current Pharmaceutical Analysis Supercritical Fluid Extraction of Bioactive Compounds from Botanic Matrices: Experimental Data, Process Parameters and Economic Evaluation
Recent Patents on Engineering Subcellular Imaging and Diagnosis of Cancer using Engineered Nanoparticles
Current Pharmaceutical Design Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?
Current Topics in Medicinal Chemistry Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Current Pharmaceutical Design Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets Association of β-tubulin, F-box/Leucine-Rich Repeat Protein 14, and Type 1 Procollagen C-peptide in Bovine Periosteal Cells
Current Tissue Engineering (Discontinued) Pharmacologic Modulators of Soluble Guanylate Cyclase/Cyclic Guanosine Monophosphate in the Vascular System - From Bench Top to Bedside
Current Vascular Pharmacology Microfluidic Methods for Non-Viral Gene Delivery
Current Gene Therapy Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets (Discontinued) New Anthocyanins from Black Elderberry of Inhibitory Potential Revealed by Mass Spectrometry
The Natural Products Journal Glycomics: Towards Bioinformatic Approaches to Understanding Glycosylation
Anti-Cancer Agents in Medicinal Chemistry Association of Phytol with Toxic and Cytotoxic Activities in an Antitumoral Perspective: A Meta-Analysis and Systemic Review
Anti-Cancer Agents in Medicinal Chemistry Antioxidant Properties and Polyphenol Screening of the Leaves of Native Hungarian Oak (<i>Quercus</i>) Species
Current Bioactive Compounds Medicinal Chemistry Design Principles for Liver Targeting Through OATP Transporters
Current Topics in Medicinal Chemistry Nanoceria: Synthesis and Biomedical Applications
Current Nanoscience Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology Molecular Imaging Strategies for In Vivo Tracking of MicroRNAs: A Comprehensive Review
Current Medicinal Chemistry Novel Non-Competitive Antagonists of Kainate GluK1/GluK2 Receptors
Letters in Drug Design & Discovery